Michael A. Desjardin - Net Worth and Insider Trading
Michael A. Desjardin Net Worth
The estimated net worth of Michael A. Desjardin is at least $10 Million dollars as of 2024-05-23. Michael A. Desjardin is the EVP, Technical Operations of Horizon Therapeutics PLC and owns about 82,346 shares of Horizon Therapeutics PLC (HZNP) stock worth over $10 Million. Details can be seen in Michael A. Desjardin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael A. Desjardin has not made any transactions after 2022-04-12 and currently still holds the listed stock(s).
Transaction Summary of Michael A. Desjardin
Michael A. Desjardin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael A. Desjardin owns 2 companies in total, including Horizon Therapeutics PLC (HZNP) , and Jazz Pharmaceuticals PLC (JAZZ) .
Click here to see the complete history of Michael A. Desjardin’s form 4 insider trades.
Insider Ownership Summary of Michael A. Desjardin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2022-04-12 | EVP & Technical Operations |
| JAZZ | Jazz Pharmaceuticals PLC | 2011-02-08 | SVP & Product Development |
Michael A. Desjardin Latest Holdings Summary
Michael A. Desjardin currently owns a total of 1 stock. Michael A. Desjardin owns 82,346 shares of Horizon Therapeutics PLC (HZNP) as of April 12, 2022, with a value of $10 Million.
Latest Holdings of Michael A. Desjardin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2022-04-12 | 82,346 | 116.30 | 9,576,840 |
Holding Weightings of Michael A. Desjardin
Michael A. Desjardin Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael A. Desjardin has made a total of 8 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 20,214 shares on April 12, 2022, which brought Michael A. Desjardin around $2 Million.
Insider Trading History of Michael A. Desjardin
- 1
Michael A. Desjardin Trading Performance
Michael A. Desjardin Ownership Network
Michael A. Desjardin Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Michael A. Desjardin is the EVP & Technical Operations of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
Over the past 18 months, Michael A. Desjardin made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Michael A. Desjardin Mailing Address
Above is the net worth, insider trading, and ownership report for Michael A. Desjardin. You might contact Michael A. Desjardin via mailing address: C/o Jazz Pharmaceuticals, Inc., 3180 Porter Drive, Palo Alto Ca 94304.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
